The type 2 cytokines interleukin (IL)-4, IL-5, IL-9 and IL-13 have important roles in stimulating innate and adaptive immune responses that are required for resistance to helminth infection, promotion of allergic inflammation, metabolic homeostasis and tissue repair 1-3 . Group 2 innate lymphoid cells (ILC2s) produce type 2 cytokines, and although advances have been made in understanding the cytokine milieu that promotes ILC2 responses 4-9 , how ILC2 responses are regulated by other stimuli remains poorly understood. Here we demonstrate that ILC2s in the mouse gastrointestinal tract co-localize with cholinergic neurons that express the neuropeptide neuromedin U (NMU) 10,11 . In contrast to other haematopoietic cells, ILC2s selectively express the NMU receptor 1 (NMUR1). In vitro stimulation of ILC2s with NMU induced rapid cell activation, proliferation, and secretion of the type 2 cytokines IL-5, IL-9 and IL-13 that was dependent on cell-intrinsic expression of NMUR1 and G αq protein. In vivo administration of NMU triggered potent type 2 cytokine responses characterized by ILC2 activation, proliferation and eosinophil recruitment that was associated with accelerated expulsion of the gastrointestinal nematode Nippostrongylus brasiliensis or induction of lung inflammation. Conversely, worm burden was higher in Nmur1 −/− mice than in control mice. Furthermore, use of genedeficient mice and adoptive cell transfer experiments revealed that ILC2s were necessary and sufficient to mount NMU-elicited type 2 cytokine responses. Together, these data indicate that the NMU-NMUR1 neuronal signalling circuit provides a selective mechanism through which the enteric nervous system and innate immune system integrate to promote rapid type 2 cytokine responses that can induce anti-microbial, inflammatory and tissue-protective type 2 responses at mucosal sites.
| A network of neuromedin-U-expressing neurons co-localizes with NMUR1 + ILC2s. a, Immunofluorescence staining of the intestinal submucosa. Scale bar, 20 μ m. b, RNA-seq volcano plot of differential expression between ILC2s (positive log 2 (fold change (FC))) and ILC3s (negative log 2 (FC)). Genes belonging to the KEGG pathway 'neuroactive receptor-ligand interaction' (mmu04080) are shown in red and are enriched among the genes differentially expressed in ILC2s (corrected P < 0.01). c, Heatmap showing expression Z-scores of the indicated genes in small intestine ILC2s and ILC3s, as measured by RNA-seq. For Nmur2, Z-scores of 0 indicate read counts of zero in all samples. d, Expression of Nmur1 and Nmur2 in the indicated sort-purified lymphocyte populations as determined by qPCR analysis (n = 3). ILC2p, ILC2 progenitor; n.d., not detectable; SI, small intestine. e, Expression of NMUR1 in the indicated sorted lymphocyte populations from human intestine as determined by qPCR analysis (n = 7). f, Dot plots show expression of Nmur1 as measured by conversion of the fluorescent LacZ substrate fluorescein di-β -d-galactopyranoside (FDG). Lineage 1: CD11b, CD11c and B220 (all APC-eF780); lineage 2: CD3, CD5 (both PerCP-Cy5.5) and Fcε RI PerCP-eF710. g, CLARITY staining of the small intestine. h, Immunofluorescence staining of the intestinal muscularis mucosae. i, Immunofluorescence staining of the intestinal submucosa. Scale bar, 100 μ m (g, h), 50 μ m (i). Error bars, mean + s.d. Data in a and f-i are representative of three independent experiments with similar results. Data are based on three (b-d) or seven (e) biological replicates per group. close inter-cellular contacts (Extended Data Fig. 1 ). To test whether neuron-derived signals might be sensed by ILC2s, we performed RNA sequencing (RNA-seq) and KEGG pathway analysis of ILC subsets. Multiple genes associated with neuroactive receptor-ligand interactions were differentially expressed between ILC2s and ILC3s (Fig. 1b) . The most differentially expressed gene in ILC2s in this category was Nmur1, a receptor for the neuropeptide NMU, which has previously been reported to provoke anorexic effects in the central nervous system and promote cutaneous inflammation 10, 11, 15, 16 . We compared Nmur1 expression to several highly differentially expressed genes found in ILC3s (Rorc, Il17f, Il1r1 and Il22) or in ILC2s (Gata3 and Il1rl1). Nmur1 expression segregated in ILC2s to a comparable degree to that noted for other ILC2-associated genes (Fig. 1c) . The selective expression of Nmur1 in ILC2s, but not in other innate and adaptive lymphocyte lineages or myeloid cells, was confirmed by quantitative PCR (qPCR) analysis ( Fig. 1d , Extended Data Fig. 2a ). In contrast, a second receptor for NMU (Nmur2), which is predominately expressed in the central nervous system 10, 11 , was not detected in any of the immune cell populations examined (Fig. 1c, d ). Expression of NMUR1 was also detectable in human intestinal ILCs, but not in B cells, suggesting that human ILCs sense neuronal signals via NMUR1 ( Fig. 1e ).
Analysis of NMUR1 protein expression using a LacZ reporter revealed that 2% of all CD45 + cells in the small intestine were NMUR1 + in Nmur1 LacZ/+ but not in control Nmur1 +/+ mice that lacked the reporter (Fig. 1f ). Analysis of NMUR1 + cells revealed that 97% of NMUR1 + cells were negative for cell lineage markers such as CD3, CD5, Fcε RI, CD11b, CD11c and B220, but expressed the ILC2 markers CD127 and KLRG1 ( Fig. 1f ). Consistent with mRNA expression, ILC2s expressed LacZ under the control of the Nmur1 promoter, whereas no expression was detected in B cells, T cells, ILC1s, ILC3s, eosinophils, mast cells, macrophages and basophils (Extended Data Fig. 2b-g) . Thus, Nmur1 is selectively expressed in ILC2s.
The ligand of NMUR1 is the 23-amino-acid-long neuropeptide NMU 10, 11 . Nmu was not detectable by qPCR in the epithelial or lamina propria fractions of the small intestine isolated from mouse or human specimens but was expressed in the parenchymal tissue of the small intestine, suggesting that haematopoietic cells do not express NMU (Extended Data Fig. 2h , i). Immunofluorescence staining of intestinal tissue or use of Nmu GFP reporter mice revealed a network of NMU + neurons including the plexus myentericus, plexus submucosus and nerve fibres that are located below the tips of the villi (Fig. 1g , Extended Data Fig. 2j -l). Notably, NMU was expressed in cholinergic (marked by choline acetyl-transferase (ChAT) expression) but not in catecholaminergic neurons (marked by tyrosine hydroxylase (TH) expression) ( Fig. 1h , Extended Data Fig. 2m ). NMU + neurons co-localized with ILC2s, and 68% of ILC2s had overlapping pixels with neurons ( Fig. 1i , Extended Data Fig. 3a, b ). Further, co-culture of ILC2s with enteric neurons that expressed NMU led to increased proliferation and blasting of ILC2s, suggesting that enteric nerve-derived bioactive factors directly activate ILC2s (Extended Data Fig. 3c-e ). Together, these data indicate that NMUR1 is specifically expressed by ILC2s, which co-localize with NMU + cholinergic neurons in the intestine and that ILC2s might sense nerve-derived signals.
To test whether NMU stimulates ILC2s, we isolated lamina propria lymphocytes (LPLs) from IL-13 reporter mice 17 and incubated them in vitro with or without NMU. NMU potently activated ILC2s as measured by IL-13 expression ( Fig. 2a, b ; for gating see Extended Data Fig. 4a ). We confirmed the capacity of NMU to induce IL-5 and IL-13 production by intracellular cytokine staining ( Fig. 2c, d ) and ELISA assays (Extended Data Fig. 4b, c ). Further, a comparison of stimulation of ILC2s with NMU versus combinations of IL-2, IL-7, IL-25 and IL-33 or PMA and ionomycin (all stimuli known to stimulate ILC2s 14, [18] [19] [20] , revealed that NMU-induced expression of IL-5 and IL-13 in ILC2s was stronger than the effects of cytokines previously known to activate ILC2s. Indeed, only a combination of IL-2, IL-7, IL-25 and IL-33 or PMA and ionomycin stimulation resulted in comparable ILC2 activation as NMU stimulation ( Fig. 2e, f ). As NMU could trigger potent cytokine production from ILC2s lacking IL-33 responsiveness, we conclude that NMU can activate ILC2s independently of IL-33 (Extended Data Fig. 4d ).
In order to investigate whether NMU activation of ILC2s requires NMUR1, we examined Nmur1 −/− mice. ILC2s developed in comparable proportions in Nmur1 −/− mice and did not exhibit obvious defects at steady-state (Extended Data Fig. 4e , f). However, only ILC2s from Nmur1 +/+ but not from Nmur1 −/− mice were activated by NMU to produce type 2 cytokines ( Fig. 2g ). In contrast, ILC2s from both genotypes could be activated by PMA and ionomycin, demonstrating that ILC2s from Nmur1 −/− were responsive to stimulation but had a specific defect in the NMUR1 signalling pathway (Fig. 2g ). In addition, chemical inhibition of G αq family of proteins, which mediate NMUR1 signal transduction 21 , completely abolished activation of ILC2s but had only modest effects on ILC2 stimulation with IL-2, IL-7, IL-25 and IL-33 ( Fig. 2h , Extended Data Fig. 4g ). Thus, NMU appears to trigger a NMUR1-and G αq -dependent signalling pathway in ILC2s.
To test whether the stimulation of NMUR1 signalling by NMU is ILC2-intrinsic, we isolated LPLs from CD45.1:Nmur1 +/+ / CD45.2:Nmur1 −/− mixed bone marrow chimaeras and stimulated Letter reSeArCH them in vitro with NMU or PMA and ionomycin. Only CD45.1 Nmur1 +/+ ILC2s but not CD45.2 Nmur1 −/− ILC2s expressed IL-5 and IL-13 following NMU stimulation, whereas ILC2s from both genotypes were activated by PMA and ionomycin (Extended Data Fig. 4h ). In addition, NMU stimulation of sort-purified ILC2s resulted in blasting and a significant increase in IL-5, IL-9 and IL-13 production, as measured by flow cytometry or by Legendplex bead-based assay ( Fig. 2i -m, Extended Data Fig. 4i -l). Therefore, we conclude that NMU promotes type 2 cytokine production from ILC2s through activating NMUR1 on ILC2s.
To further elucidate the pathways activated in ILC2s by NMU stimulation, we sort-purified ILC2s from phosphate-buffered saline (PBS)-or NMU-treated mice and performed transcriptional profiling by RNAseq. Transcripts from PBS-and NMU-treated ILC2s clustered separately ( Fig. 3a ) and gene-ontology-term analysis revealed that NMU activates processes related to cell cycle regulation and cell division ( Fig. 3b ), including expression of the cell-cycle-associated genes Kntc1, Chaf1a, Cdc6, Spag5, Brca1, Mki67 and Cdca3 (Fig. 3c ). Flow cytometric analysis for Ki67, the protein encoded by MKi67, demonstrated that NMU administration resulted in significantly increased proliferation of ILC2s, but not of ILC3s ( Fig. 3d , e, Extended Data Fig. 5a ). Injection of NMU into CD45.1:Nmur1 +/+ /CD45.2:Nmur1 −/− mixed bone marrow chimaeras revealed an ILC2-intrinsic requirement for NMUR1 to respond to NMU in vivo ( Fig. 3f , Extended Data Fig. 5b-d ).
In addition, in vivo delivery of NMU induced blasting (Extended Data Fig. 5e ) and maturation ( Fig. 3g ) of ILC2s that was associated with prototypic type 2 inflammation marked by production of IL-13 ( Fig. 3h , i) and goblet cell hyperplasia ( Fig. 3j, k) .
As the intestine is highly innervated by a network of NMU + neurons ( Fig. 1i ), we investigated the role of NMU in immunity to the helminth Blue, not significant (P corrected > 0.01) (b). Heatmap showing expression Z-scores of selected differentially expressed genes between PBS-or NMU-treated mice (c). d-f, PBS or NMU was injected daily for two days in C57BL/6 mice (d, e) or in CD45.1:Nmur1 +/+ /CD45.2:Nmur1 −/− chimaeras (f). One day later, ILC2s from the small intestine were analysed by flow cytometry for KLRG1 and Ki67 expression. Plots are gated on Lin − CD45 + CD25 + KLRG1 + lymphocytes (d). Percentage (n = 3 (e), n = 4 (PBS), n = 5 (NMU) (f)) of Ki67 + KLRG1 + cells (e, f). g-i, PBS or NMU was injected in Il13 YFP/+ mice. MFI of KLRG1 expression (g). Histogram overlay for IL-13 (h) is gated on Lin − CD45 + CD127 + CD25 + KLRG1 + lymphocytes and percentage (n = 3) of IL-13 YFP + KLRG1 + cells among all KLRG1 + cells (i) one day after injection. j, k, PAS staining after PBS or NMU administration (j). Scale bar, 100 μ m. Goblet cell number (n = 4 (PBS), n = 5 (NMU)) per villus (k). l, C57BL/6 mice were infected with N. brasiliensis or untreated. parasite Nippostrongylus brasiliensis, an intestinal parasite infection model, in which immunity is critically dependent on activation of ILC2s 17, 22, 23 . Consistent with a role for NMU in regulating ILC2 responses during helminth infection, Nmu expression was upregulated following infection with N. brasiliensis and was a conserved response following exposure to the related nematode parasites Trichuris muris and Heligmosomoides polygyrus (Fig. 3l , Extended Data Fig. 5f , g). As NMUR1 is specifically expressed on ILC2s at steady state ( Fig. 1d , f, Extended Data Fig. 2b -g), we tested whether NMUR1 is induced on other cell types following exposure to N. brasiliensis infection. Although increased Nmur1 expression was detected on ILC2s (Extended Data Fig. 5h ), Nmur1 expression was still specific to ILC2s and not detected on sizable proportions of other immune cell populations including mast cells, basophils, macrophages, T cells or IL-4-producing T H 2 cells, indicating that NMU is not acting directly on other haematopoietic cells (Fig. 3m , Extended Data Fig. 5i -l). However, in order to rule out that some of the effects of NMU in vivo require mast cells or eosinophils, in which Nmur1 was detected in previous publications 15, 24 , we injected NMU in mast-cell-deficient or eosinophil-deficient mice. Consistent with our Nmur1 expression results, NMU elicited ILC2 activation in mast-cell-deficient Cpa3 cre/+ and eosinophil-deficient Δ dblGATA1 mice, demonstrating that ILC2 activation by NMU is independent of eosinophils and mast cells in vivo (Extended Data Fig. 5m -o).
Delivery of NMU during N. brasiliensis infection was associated with elevated eosinophilia and accelerated worm expulsion ( Fig. 3n, o) . N. brasiliensis-infected Nmur1-deficient mice and Nmur1 −/− bone marrow chimaeras exhibited elevated worm burden and reduced ILC2 responses (Fig. 3p, q, Extended Data Fig. 5p ). To test whether there is a cell-intrinsic role for NMUR1 on ILC2s, we reconstituted Rag2 −/− Il2rg −/− mice with ILC2 progenitors derived from either Nmur1 +/+ or Nmur1 −/− mice. Accelerated worm expulsion and increased ILC2 numbers were observed in recipients reconstituted with Nmur1 +/+ ILC2 progenitors compared to those reconstituted with Nmur1 −/− ILC2 progenitors (Fig. 3r, s) . Administration of NMU to Rag2 −/− Il2rg −/− mice reconstituted with ILC2 progenitors derived from either Nmur1 +/+ or Nmur1 −/− mice resulted in enhanced worm expulsion and type 2 response in mice reconstituted with Nmur1 +/+ precursors, indicating that NMU stimulates ILC2s in vivo and promotes ILC2-dependent immunity to infection ( Fig. 3t -v, Extended Data Fig. 5q ).
To investigate whether NMU can influence ILC2 responses at other mucosal barriers, we delivered NMU intranasally. NMU administration stimulated maturation, cytokine expression and proliferation of lung ILC2s (Fig. 4a-c, Extended Data Fig. 6a ). Associated with this, NMU administration resulted in increased eosinophilia in bronchoalveolar lavage (BAL) and lung tissue and enhanced mucus production compared to PBS-treated control animals ( Fig. 4d , e, Extended Data Fig. 6b ). To directly test whether NMU-induced lung inflammation is dependent on ILC2s, NMU was administered to ILC2-sufficient Rag2 −/− versus ILC2-deficient Rag2 −/− Il2rg −/− mice. NMU administration to Rag2 −/− mice resulted in robust ILC2 activation, eosinophil recruitment and airway inflammation compared to PBS-treated Rag2 −/− mice, whereas no recruitment of eosinophils was observed in Rag2 −/− Il2rg −/− mice (Fig. 4f, g, Extended Data Fig. 6c ). Reconstitution of Rag2 −/− Il2rg −/− mice with ILC2 progenitors 14 restored ILC2 populations in the lung (Extended Data Fig. 6d ) and delivery of NMU resulted in robust ILC2 proliferation and eosinophilia that was absent in ILC2deficient recipients (Fig. 4h, i) . Lastly, delivery of NMU to Nmur1 +/+ or Nmur1 −/− mice demonstrated the requirement for NMUR1 in eliciting NMU-dependent ILC2 responses in vivo (Fig. 4j , k, Extended Data Fig. 6e ).
Taken together, these findings elaborate a previously unrecognized pathway that enables neuronal-immune system cross-talk and identify a role for cholinergic neuron-derived NMU in promoting activation, proliferation and effector functions of ILC2s at mucosal sites. The discovery that NMU can promote ILC2 responses and accelerate type 2 inflammation suggests that beyond their capacity to respond to cytokines and alarmins, ILC2s may have selectively co-evolved with the enteric nervous system to coordinate early sensing and responsiveness to infectious and foreign stimuli at barrier surfaces. We propose that cholinergic enteric neuron-derived neuromedin U functions as a neuronal amplifier that primes ILC2s for rapid and optimal activation by promoting their entry into the cell cycle or their responsiveness to other host-derived or environmental stimuli, which are essential activation and/or survival factors for ILC2s. Moreover, the appreciation that the immediate response capability of the nervous system can elicit a strong, rapid and selective activation of ILC2s provides new insights into the pathophysiology of innate type 2 cytokine responses associated with exposure to multiple infectious agents, environmental allergens and pollutants at mucosal sites. 32 ) and the strains mentioned below, were bred at Weill Cornell Medicine. Nmur1 LacZ/+ (Nmur1 tm1.1(KOMP)Vlcg ) were generated by Velocigene using C57BL/6 embryonic stem cells in which the Nmur1 gene was replaced by LacZ and a floxed neomyin cassette. The neomycin cassette was removed by crossing the mice to Cre deleter mice. Breeding of Nmur1 LacZ/+ to homozygosity resulted in Nmur1-deficient (Nmur1 LacZ/LacZ ) mice referred to as Nmur1 −/− . Nmu GFP were generated by Gensat and provided on a Swiss Webster background. Sex-and age-matched animals between 6 and 16 weeks of age were used for experiments if not otherwise indicated. We did not use randomization to assign animals to experimental groups. Investigators were not blinded to group allocation during experiments. No animals were excluded from the analysis unless clearly indicated. All animal experiments were approved and are in accordance with the Institutional Animal Care and Use Committee guidelines at Weill Cornell Medicine.
Isolation of cells from the lamina propria and the lung. Small intestine was removed, cleaned from remaining fat tissue and washed in ice-cold PBS (Corning).
Peyer's patches were identified and eliminated. Small intestine was opened longitudinally and washed in ice-cold PBS. Dissociation of epithelial cells was performed by incubation on a shaker at 37 °C in HBSS (Sigma-Aldrich) containing 10 mM Hepes and 5 mM EDTA (both Thermo Fisher Scientific) or 1 mM DTT (Sigma-Aldrich) two times for 15 min. After each step, samples were vortexed and the epithelial fraction discarded. Afterwards, remaining tissue was chopped into small pieces and enzymatic digestion was performed using dispase (0.4 U/ml; Thermo Fisher Scientific), collagenase III (1 mg/ml; Worthington) and DNaseI (20 μ g/ml; Sigma-Aldrich). Leukocytes were further enriched by a 40%/80% Percoll gradient centrifugation (Sigma-Aldrich).
One PBS-perfused lung lobe was minced and incubated using same conditions and enzymatic cocktail as for the intestine for 45 min at 37 °C. Afterwards lung was vortexed, mashed through a 70-μ m cell strainer and purified over a 40%/80% Percoll gradient.
Mesenteric lymph nodes were chopped and incubated in RPMI medium supplemented with 1% BSA (Sigma-Aldrich), DNaseI (20 μ g/ml) and collagenase II (1 mg/ml; Sigma-Aldrich) for 20 min at 37 °C. Specimens were mechanically dissociated and filtered through a 70-μ m cell strainer. Flow cytometry and cell sorting. After saturating the Fc-receptors with CD16/ CD32-blocking antibody (Biolegend), single-cell suspensions were incubated on ice with conjugated antibodies in PBS (Ca 2+ and Mg 2+ -free). Dead cells were routinely excluded with Fixable Aqua Dead Cell Stain or SYTOX Blue Dead Cell Stain (Thermo Fisher Scientific). Lineage-positive cells were excluded by staining for CD3ε (145-2C11), CD5 (53-7.3), Fcε RI (Mar-1), B220 (RA3-6B2), CD11b (M1/70) and CD11c (N418). For surface staining KLRG1 (2F1), CD45 (30-F11), CD45.1 (A20), CD45.2 (104), CD25 (PC61), CD127 (A7R34), SiglecF (E50-2440), CCR6 (29-2L17), NKp46 (29A1.4), NK1.1 (PK136), c-kit (2B8), CD49b (HMα 2), CD19 (eBio1D3), CD90.2 (53-2.1), ST2 (DIH9) and F4/80 (BM8) were used. Intracellular staining with IL-5 (TRFK5) and IL-13 (eBIO13A) antibodies was carried out by using the Cytofix/Cytoperm Fixation/Permeabalization Solution and Perm/Wash buffer (BD Biosciences). GATA-3 (TWAJ), RORγ t (B2D) and Ki67 (B56) were stained using the Foxp3 transcription factor staining buffer set (eBioscience). Human ILCs were sort-purified as CD45 + (HI30), CD3ε − (UCHT1), CD5 − (UCHT2), CD19 − (HIB19), CD11b − (CBRM1/5), CD11c − (3.9), CD14 − (HCD14) and CD127 + (eBioRDR5) cells. All antibodies used in flow cytometry were purchased from eBioscience, Biolegend or BD Biosciences. LacZ was visualized by using the FluoReporter LacZ Flow Cytometry Kit according to the manufacture's protocol (Thermo Fisher Scientific) and 2 min incubation time. All flow cytometry experiments were acquired using a custom configuration Fortessa flow cytometer and the FACS Diva software (BD Biosciences) and analysed with FlowJo V9.9.3 software (TreeStar) or sort-purified by using a custom configuration FACSAria cell sorter (BD Biosciences). Quantitative real-time PCR. Tissues and sorted cells were homogenized in Trizol (Thermo Fisher Scientific) and stored at − 80°C. RNA was extracted with chloroform and RNA concentration was determined using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific). Reverse transcription of total RNA was performed using the High Capacity cDNA Reverse Transcription kit according to the protocol provided by the manufacturer (Thermo Fisher Scientific). Reaction was detected on a QuantStudio 6 Flex Real-Time PCR (Thermo Fisher Scientific) using the following TaqMan Gene Expression Assays (Applied Biosystems): Nmu (Mm00479868_m1), Nmur1 (Mm00515885_m1), Nmur2 (Mm00600704_m1) for mouse and NMU (Hs00183624_m1), NMUR1 (Hs00173804_m1) for human samples. Gene expression was normalized as n-fold difference to the gene Hprt1 (Mm00446968_m1) for mouse and HPRT1 (Hs02800695_m1) for human samples according to the cycling threshold. Calculation of mRNA levels was performed with the QuantStudio Real-Time PCR software version 1.0 (Thermo Fisher Scientific). In vitro stimulation and ELISA. Bulk LPLs or sort-purified ILC2s were incubated in DMEM with high glucose supplemented with 10% FCS, 10 mM Hepes, 1 mM sodium pyruvate, non-essential amino acids, 80 μ m 2-mercaptoethanol, 2 mM glutamine, 100 U/ml penicillin and 100 μ g/ml streptomycin (all from Gibco) in 96-well microtiter plates (Corning) for 4 h at 37 °C and 5% CO 2 . Neuromedin U-23 (Phoenix Pharmaceuticals or Alpha Diagnostics) or a control peptide (Alpha Diagnostics) were added at 0.1 (Fig. 2e, f, h) , 1 ( Fig. 2a-d , g) or 10 μ g/ml ( Fig. 2i-m) if not otherwise indicated. If indicated, the culture was supplemented with phorbol 12-myristate 13-acetate (PMA, 1 μ g/ml) and ionomycin (Sigma-Aldrich, 1 μ g/ml), IL-2, IL-7, IL-33 (R&D, 100 ng/ml, each) and/or IL-25 (eBioscience, 100 ng/ml). The inhibitor of G αq proteins FR900359 was purified at the University of Bonn and used at 1 μ M concentration. In experiments in which intracellular cytokine staining was performed, brefeldin A was added (Sigma-Aldrich, 10 μ g/ml).
Cytokines in the supernatants were detected with a sandwich ELISA using IL-5 (TRFK5) or IL-13 (eBio13a) as capture antibodies and IL-5 (TRFK4) or IL-13 (eBio1316H) as detection antibodies (all from eBioscience) or the Legendplex bead-based assay (Biolegend) for IL-5, IL-9 and IL-13 according to the manufacture's protocol. Helminth infection. Third-stage larvae (L3) of N. brasiliensis were purified with a Baermann apparatus. After washing three times in PBS, living worms were counted. 500 purified larvae were injected subcutaneously in PBS. In addition, in some experiments PBS or NMU (20 μ g, Phoenix Pharmaceuticals) was injected i.p. on day 2, 4 and 6 of infection. At day 7 of infection, mice were killed and analysed if not otherwise indicated. For T. muris infection, 200 embryonated eggs were administered by oral gavage. At day 18, a piece from the proximal colon was removed and cleaned in PBS, after which RNA was extracted for qPCR. For H. polygyrus, 250 infective L3 larvae were administered by oral gavage. At day 18, a piece from the duodenum was removed and cleaned in PBS, after which RNA was extracted for qPCR. RNA-seq analysis. For the RNA-seq data presented in Fig. 1, ILC2 (Lin − CD45 + CD90 + CD127 + KLRG1 + ) and ILC3 (Lin − CD45 + CD90 + CD127 + CCR6 + ) lymphocytes were sort-purified from the small intestine of C57BL76 mice. For the RNA-seq data presented in Fig. 3 , PBS or NMU (20 μ g, Phoenix Pharmaceuticals) was injected into Id2 GFP/+ mice. After one day, ILC2s from the small intestine were sort-purified as Lin − CD45 + ID2 + GFP + CD127 + CD25 + KLRG1 + lymphocytes in Trizol and stored at − 80°C. RNA was extracted by using chloroform and further purification with the RNAeasy mini spin columns (Qiagen). RNA samples with an average RNA integrity number (RIN) of 7.9 were further processed.
Sorted cells were used to prepare RNA-seq libraries by the Epigenomics Core at Weill Cornell Medicine using the Clontech SMARTer Ultra Low Input RNA Kit V4 (Clontech Laboratories). Sequencing was performed on an Illumina HiSeq 2500, yielding 50 bp single-end reads.
Raw sequencing reads were demultiplexed with Illumina CASAVA (v1.8.2). Adapters were trimmed from reads using FLEXBAR (v2.4) 33 and reads were aligned to the NCBI GRCm38/mm10 mouse genome using the STAR aligner (v2.3.0) 34 with default settings. Reads per gene were counted using Rsubread 35 . One sample was removed from the analysis, as its library size was anomalously small compared to those of the other samples. Genes with at least 10 counts in each sample were considered for further analysis. Differential expression was assessed using DESeq2 version 1.14.0 with default parameters and with a false discovery rate (FDR) of 0.1 (ref. 36) . Principal component analysis was performed after using DESeq2 variance stabilizing transformation. Gene Ontology and KEGG term enrichment analysis of differentially expressed genes was performed using the goana and kegga functions of the limma R package 37 . Enrichment P values were then Bonferroni-corrected. NMU-induced inflammation. NMU (20 μ g) or sterile PBS was intranasally administered in a total volume of 30 μ l daily. Administration was either performed for 5 days and mice were analysed after 3 days rest, or analysed on day 5 after 4 days of administration. Generation of bone marrow chimaeras. Mice were irradiated with 11 Gy from an X-ray irradiator split in two doses of 5.5 Gy and a 4h break between the two cycles. For mixed bone marrow chimaeras CD45.1 mice were reconstituted with a 1:1 mixture of full bone marrow from CD45.1:Nmur1 +/+ and CD45.2:Nmur1 −/− mice. For bone marrow chimaeras C57BL/6 mice were reconstituted with either Nmur1 +/+ or Nmur1 −/− bone marrow. Antibiotics (sulfamethoxazol and trimethoprim) were delivered for 2 weeks after bone marrow transplantation in the drinking water and mice were reconstituted for at least 6 weeks before experimentation. Reconstitution of Rag2 −/− Il2rg −/− mice. Bones were cleaned, washed in 70% EtOH and subsequently in PBS and crushed using a pestle. Bones were rinsed with PBS and bone marrow was resuspended in PBS and filtered through a 70-μ m cell strainer. Red blood cells were lysed using ACK buffer (Lonza) and lineage-positive cells were depleted using the Dynabeads untouched mouse CD4 cells kit according to the manufacture's protocol (Thermo Fisher Scientific). Remaining cells were stained and ILC2 progenitors were sort-purified as Lin − Sca-1 hi CD127 + CD25 + cells 14 . 1 × 10 4 sort-purified ILC2 progenitors were injected i.v. and mice were used at least 4 weeks after adoptive transfer. Clarity imaging and immunofluorescence. CLARITY imaging was performed following a modified protocol of Chung et al. 38 . Briefly, mice were killed and transcardially perfused with 20 ml of ice-cold PBS followed by hydrogel solution combining 1% acrylamide (40%, BioRad), 0.025% bis-acrylamide (2%, BioRad), 0.25% VA-044 initiator (Wako) and 4% PFA in PBS. Intestines were immediately excised, opened longitudinally and cleaned. Tissue was placed in a 50 ml conical tube including 20 ml of cold hydrogel solution and incubated slowly shaking at 4 °C for 2 days. The tube was degassed in a desiccation chamber to replace air with nitrogen gas and submerged in a 37 °C water bath for 4 h until polymerization of the hydrogel solution. Tissue was extracted and cleaned of excess gel followed by washing in clearing solution (200 mM Boric Acid, 4% Sodium Dodecyl Sulphate (pH 8.5; both Sigma-Aldrich) at 37 °C on a shaker. Clearing solution was changed every 2 days until tissue became transparent. Tissue was washed twice for 24 h in 0.1% Triton X-100 in PBS and stained with indicated antibodies.
For whole mount staining small intestine was cleaned, opened longitudinally and washed ice-cold HBSS with 5% FCS and HBSS with 1 mM DTT. The muscularis mucosae was then mechanically separated from the mucosa using forceps and washed ice-cold HBSS with 5% FCS. The tissue was fixed in 4% PFA for 2 h at room temperature. Afterwards the tissue was washed in ice-cold PBS and blocked with PBS 0.1% Triton X-100 and 10% serum and stained. The following antibodies were used: rabbit anti-NMU (Santa Cruz), chicken anti-tyrosine-hydroxylase (Abcam), mouse anti-SNAP25 (SMI 81, Biolegend), rat anti-CD3ε (17A2, Biolegend), hamster anti-KLRG1 (2F1, eBioscience) followed by goat anti-rabbit Alexa 488, donkey anti-rabbit Alexa 647, goat anti-chicken Alexa 555, goat anti-hamster Alexa 546 (all Thermo Fisher Scientific), donkey anti-rat Alexa 647 (Jackson Immuno Research), and images of representative tissue were captured under a LSM 880 confocal microscope and analysed with Zen software (Zeiss). Surface reconstruction was performed by using Imaris software (Bitplane). For quantification of ILC2neuron co-localization we performed background subtraction, and Gaussian smoothing. Then a surface was created and small objects were filtered out for the CD3ε channel. Afterwards, the KLRG1 channel was masked with CD3ε objects in order to remove these from the KLRG1 channel. Background subtraction, Gaussian smoothing, creation of surface and filtering of small objects were performed for KLRG1 channel. This mask was used to select pixels in the NMU channel that overlap with KLRG1. For the masked NMU channel, a surface was created and small objects were filtered out. The objects with and without overlap of the KLRG1 and NMU channel were manually counted. Enteric neuron culture. Neurosphere culture and differentiation was essentially carried out as described before 39 . In brief, the intestine were dissected from embryos approximately 18 days p.c., minced and washed four times in HBSS/2% FBS (4 min, at 400 g). Tissue was digested for 15 min at 37 °C in HBSS supplemented with 0.05% Trypsin-EDTA solution (Gibco) and 50 μ g/ml DNaseI. After digestion the solution was vortexed and filtered through a 70-μ m cell strainer. Cells were plated on an ultralow adherent plate (Corning) in DMEM/ F12 supplemented with N2 and Antibiotic-Antimycotic solution (all Gibco) and expanded for 4-5 days. EGF and FGF (20 ng/ml, both R&D) were added to the culture. For differentiation, cells were plated on a 96-well flat-bottom adherent plate (Corning) coated with fibronectin (20 μ g/ml in PBS, Sigma) in Neurobasal medium supplemented with B27 and antibiotic-antimycotic solution (all Gibco) for 15 days. For co-culture, sort-purified ILC2s were added to the culture with IL-2 and IL-7 (20 ng/ml each).
Human tissues. Human tissues were obtained through an approved research protocol and material transfer agreement with LiveOnNY as described before 40 . Donors were tested to be HIV − , hepatitis B − , hepatitis C − and did not have chronic disease or cancer. This work does not qualify as 'human subject' research as confirmed by the institutional review board of Columbia University. Tissues were collected after the donor organs were flushed with preservation solution. The intestinal tissue, was washed in PBS, cleaned from fat tissues and cut in smaller pieces, which were incubated in HBSS supplemented with 10 mM Hepes, 5 mM EDTA and 1 mM DTT for 1 h at 37 °C in a shaking incubator. The specimens were vortexed and filtered through a cell strainer. Epithelium and intraepithelial lymphocytes (IELs) were purified with a 20%/40% Percoll gradient. Digestion solution (collagenase D, Roche, 2 mg/ml), trypsin inhibitor (Thermo Fisher, 1 mg/ml), and DNaseI (0.1 mg/ml) in RPMI medium (Corning), was injected submucosally into the remaining tissue pieces. After incubation at 37 °C for 30 min, the samples were chopped and moved to shaking incubator for another 30 min at 37 °C. Afterwards, specimens were vortexed, filtered through a tissue sieve and purified over a 40%/80% Percoll gradient. Recovered LPLs were stained with fluorescent-label coupled antibodies and sort-purified. In addition, RNA was extracted from fractioned epithelium, intraepithelial lymphocytes, lamina propria lymphocytes, remaining parenchyma or whole unfractionated tissue using Trizol. Statistical analysis. P value of mouse data sets was determined by paired or unpaired two-tailed Student's t-test with 95% confidence interval. Normal distribution was assumed. If equal variances between two groups could not be assumed, Welch's correction was performed. Data from human samples were analysed using a two-tailed Mann-Whitney test with 95% confidence interval. All statistical tests were performed with Graph Pad Prism V7 software. (* P < 0.05; * * P < 0.01 and * * * P < 0.001; NS, not significant). Data availability. RNA-seq data are deposited under accession number GSE101625 in the Gene Expression Omnibus database.
Life Sciences Reporting Summary
Nature Research wishes to improve the reproducibility of the work we publish. This form is published with all life science papers and is intended to promote consistency and transparency in reporting. All life sciences submissions use this form; while some list items might not apply to an individual manuscript, all fields must be completed for clarity. No statistical methods were used to predetermine sample size. We chose to use 4 NSG mice per experimental group so that technical replicate tumours could be available for barcode data analysis.
Data exclusions
Describe any data exclusions. Mice which did not harbour tumours at the pre-determined endpoint (6 months post-injection) were not used for immunohistochemistry or barcode sequencing analysis.
Replication
Describe whether the experimental findings were reliably reproduced. Attempts to replicate our drug assays have been successful (n = 3 independent experiments). We did not attempt to replicate in vivo barcoding experiments due to limiting numbers for uncultured GBM cells.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
NSG mice from separate litters were randomized to vehicle control or TMZ treatment groups in order to control for age.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For xenograft studies, investigators were not blinded during group allocation and data analysis. Investigators were blinded during data collection for in vitro limiting dilution analyses (LDA).
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
